Recombinant human insulin (HEC Pharm)

重组人胰岛素 (东阳光)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human insulin (HEC Pharm)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2020/06/05
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYichang Hec Changjiang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYichang Hec Changjiang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A